These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Targeting cyclin-dependent kinases in anti-neoplastic therapy.
    Author: Bruyère C, Meijer L.
    Journal: Curr Opin Cell Biol; 2013 Dec; 25(6):772-9. PubMed ID: 24011867.
    Abstract:
    Cell cycle progression is controlled by sequential activation of cyclin-dependent kinases (CDKs), which are often deregulated in cancer. Consequently numerous pharmacological inhibitors of CDKs have been developed with the aim of treating cancers. The article briefly reviews CDK inhibitors and their use to treat cancers, with specific focus on the use of biomarkers and drugs combination to improve their therapeutic efficacy.
    [Abstract] [Full Text] [Related] [New Search]